Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Charlton

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Pharmacology|September 2, 2009
Agonist efficacy and receptor desensitization: from partial truths to a fuller pictureSteven J Charlton
British Journal of Pharmacology|October 28, 2010
Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assaysSteven J Charlton, Georges Vauquelin
British Journal of Pharmacology|January 22, 2013
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligandsGeorges Vauquelin, Steven J Charlton
British Journal of Pharmacology|October 1, 2010
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug actionGeorges Vauquelin, Steven J Charlton
British Journal of Pharmacology|September 3, 2011
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonistsDavid A Sykes, Steven J Charlton
British Journal of Pharmacology|July 19, 2006
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptorMark R Dowling, Steven J Charlton
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Single Step Determination of Unlabeled Compound Kinetics Using a Competition Association Binding Method Employing Time-Resolved FRETDavid A Sykes, Steven J Charlton
Assay and Drug Development Technologies|November 25, 2005
Assessing the minimum number of data points required for accurate IC50 determinationRobert J Turner, Steven J Charlton
Molecular Pharmacology|December 8, 2010
Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteinsElizabeth M Rosethorne, Steven J Charlton
Molecular Pharmacology|January 13, 2018
Biased Agonism in Drug Discovery-Is It Too Soon to Choose a Path?Martin C Michel, Steven J Charlton
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|September 2, 2009
Agonist efficacy and receptor desensitization: from partial truths to a fuller pictureSteven J Charlton
British Journal of Pharmacology|October 28, 2010
Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assaysSteven J Charlton, Georges Vauquelin
British Journal of Pharmacology|January 22, 2013
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligandsGeorges Vauquelin, Steven J Charlton
British Journal of Pharmacology|October 1, 2010
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug actionGeorges Vauquelin, Steven J Charlton
British Journal of Pharmacology|September 3, 2011
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonistsDavid A Sykes, Steven J Charlton
British Journal of Pharmacology|July 19, 2006
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptorMark R Dowling, Steven J Charlton
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Single Step Determination of Unlabeled Compound Kinetics Using a Competition Association Binding Method Employing Time-Resolved FRETDavid A Sykes, Steven J Charlton
Assay and Drug Development Technologies|November 25, 2005
Assessing the minimum number of data points required for accurate IC50 determinationRobert J Turner, Steven J Charlton
Molecular Pharmacology|December 8, 2010
Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteinsElizabeth M Rosethorne, Steven J Charlton
Molecular Pharmacology|January 13, 2018
Biased Agonism in Drug Discovery-Is It Too Soon to Choose a Path?Martin C Michel, Steven J Charlton
Pageof 7